Therapeutic agents for glomerulosclerosis

   
   

An object of the present invention is to provide pharmaceutical compositions for inhibiting mesangial cell proliferation or mesangial matrix production without causing hypercalcemia. According to the present invention, therapeutic agents for glomerulosclerosis containing 1.alpha.,3.beta.-dihydroxy-20.alpha.-(3-hydroxy-3-methylbutyloxy)-9,10-sec o-5,7,10 (19)-pregnatriene as an active ingredient are provided.

Un oggetto di presente invenzione รจ fornire le composizioni farmaceutiche per l'inibizione la proliferazione mesangial delle cellule o della produzione mesangial della tabella senza causare il hypercalcemia. Secondo la presente invenzione, agenti terapeutici per il glomerulosclerosis che contiene 1.alpha., 3.beta.-dihydroxy-20.alpha.-(3-hydroxy-3-methylbutyloxy)-9, 10-sec o-5,7,10 (19)-pregnatriene come ingrediente attivo sono forniti.

 
Web www.patentalert.com

< Enteral formulation

< L-ergothioneine, milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage

> Hydrophobicized copolymers

> Allantoin-containing skin cream

~ 00166